The 5705-designation memo is signed by the managed care organization's medical director — or a formally delegated physician reviewer acting under written authority — not by the claims examiner, the intake nurse, or the requesting provider. That signature assigns a specific, licensed physician to conduct the initial peer review and anchors the legal defensibility of the entire utilization review record.
The signature looks like an administrative formality. It is not. It is the single point where a health plan converts a coverage question into a physician-to-physician clinical review, and every downstream obligation — credential matching, conflict screening, timeliness clocks, and appeal rights — attaches to it. Understanding who signs, what authority they hold, and how the delegation chain works explains why some denials survive external review and others collapse on procedural grounds.
The signature mechanism: authority, delegation, and the chain of command
A 5705-designation memo is an internal assignment instrument. It names the reviewing physician, states the clinical question, identifies the criteria set in use, and records the date and time the review was assigned. The signature line belongs to someone with delegated medical-management authority.
In most plan structures that person is the medical director or a physician designee. The medical director holds enterprise-level accountability for review decisions. A designee — often an associate medical director or a lead physician reviewer — signs only when a written delegation policy exists and is current. The delegation must be documented before the signature, not reconstructed after a dispute.
The mechanism matters because peer review is legally a physician act. A non-physician can assemble the file, confirm eligibility, and prepare the criteria worksheet. A non-physician cannot assign which physician renders the clinical judgment. When a claims examiner signs a 5705 memo, the review is procedurally defective even if the clinical conclusion is correct.
Three questions test any signature. Does the signer hold current delegated authority in writing? Does the memo identify the assigned reviewer by name and license? Does the assignment occur before the reviewer opens the clinical record? Affirmative answers on all three make the memo defensible.
In plain terms, the memo is the handoff document, and only someone with clinical authority can make the handoff.
Quantified context: timelines, volumes, and threshold numbers
Utilization review operates on clocks, and the 5705 signature starts them. For non-urgent pre-service requests, many plans work against a 15-calendar-day outer limit, with a 5-business-day target for standard commercial reviews. Expedited requests compress the window to 72 hours, and urgent concurrent reviews often carry a 24-hour benchmark.
The initial peer review itself is frequently expected within 1 to 3 business days of assignment for standard cases. Expedited cases compress that to hours. Each state's review statute and each accreditation standard set their own numbers, so the exact thresholds depend on the governing framework. The principle is stable: the signature date and time, not the decision date, establishes when the clock started.
Volume shapes the risk. A mid-size plan processing several thousand prior authorizations monthly may generate hundreds of 5705 memos, and a meaningful share involve clinical criteria that require physician judgment. At that scale, signature hygiene becomes a compliance function rather than a clerical one.
The counterintuitive detail is that a late signature can invalidate a timely decision. If the assigned reviewer completes the analysis on day two but the memo is signed on day nine, the record shows an assignment gap that external reviewers treat as a procedural failure. Speed of clinical work does not cure slow paperwork.
Comparison: who signs versus who cannot
| Role | Signs the 5705 memo | Authority basis | Common failure mode |
|---|---|---|---|
| Plan medical director | Yes | Enterprise medical-management authority | Signs outside specialty scope |
| Associate or lead physician reviewer | Yes, with written delegation | Delegation policy, current and dated | Delegation expired or undocumented |
| Contracted external physician reviewer | Yes, within the vendor's delegated scope | Vendor contract plus plan delegation | No documented link to the plan's authority |
| Clinical reviewer nurse | No | Clinical support only | Signs as a convenience; review voidable |
| Claims examiner or intake specialist | No | Administrative processing only | Signs to close a queue; procedural defect |
| Requesting or treating physician | No | Treating role, conflict of interest | Cannot assign their own reviewer |
The table's logic is simple: signature authority follows clinical accountability. Anyone who cannot be held clinically accountable for the review outcome should not be assigning the reviewer.
Edge cases: delegation chains, vendor networks, and specialty mismatches
Delegation can be layered, and layering is where signatures fail. A plan delegates utilization review to a vendor. The vendor's medical director signs 5705 memos. That signature is valid only if the vendor contract expressly conveys assignment authority and the plan's delegation policy names the vendor role. Two written links are required, not one.
Specialty matching creates a second edge case. The signer assigns a reviewer, but the memo should also confirm that the reviewer's license and board status match the clinical question. A cardiology question assigned to an internist may satisfy the signature requirement while failing the peer-matching requirement. Both obligations ride on the same memo.
Urgent and concurrent reviews compress everything. When a patient is mid-treatment and the plan needs an immediate physician opinion, the 5705 memo may be signed and acted on within the same shift. That speed is legitimate only if the delegation policy anticipates after-hours signing and names who may sign when the medical director is unavailable.
A third edge case involves retrospective review. Post-service reviews still require physician assignment for clinical denials, and the memo date determines which criteria version governs. Assigning a reviewer before confirming the date of service can attach the wrong criteria set to the file.
Red-flag warnings for anyone auditing these memos:
A memo signed by a non-physician with no delegation language anywhere in the policy file. An assigned reviewer whose license does not match the clinical question and no documented exception. A signature date that precedes the assignment date or follows the decision date. Delegation policies that are undated, expired, or silent on after-hours authority. Vendor-signed memos with no contract clause conveying assignment authority. A reviewer assigned to a case involving their own patient, partner, or employer.
Each of these is a procedural vulnerability, and external review bodies weigh procedure alongside clinical merit.
Misconceptions: what the signature does and does not do
The most common misconception is that the signing physician makes the denial decision. The signer assigns the reviewer. The assigned reviewer renders the clinical determination. Separating those roles protects objectivity.
A second misconception treats the signature as a rubber stamp on a completed review. The sequence is the reverse. Assignment precedes review, and the memo should exist before the clinical record is examined.
A third misconception assumes any physician in the organization can sign. Authority is delegated, not implied by licensure. A staff physician without a delegation appointment has no assignment authority regardless of seniority.
Finally, people often assume the signature is invisible to patients and regulators. It is not. External review and state audit processes routinely request the assignment memo, and its date, signer, and reviewer identity become part of the appeal record.
In everyday language, the signature is the receipt showing the right person handed the case to the right doctor at the right time.
Practical actions: verifying or building a defensible 5705 record
For compliance staff, auditors, and plan operations teams, these steps convert the memo from paperwork into evidence:
Confirm the delegation policy is written, dated, current, and names every role authorized to sign. Retire expired versions. Require the memo to record the signer's name, title, delegation reference, and the exact date and time of assignment. Verify the assigned reviewer's license and board status against the clinical question before the review begins. Run a conflict screen against the patient, the requesting provider, and the treating facility at assignment. Attach the memo to the case file before the reviewer accesses the record, and timestamp both events. For vendor-signed memos, confirm the contract clause conveying assignment authority is on file and referenced.
For clinicians and patients navigating an appeal, request the assignment memo as part of the case file. If the signer lacks delegation authority, the procedural argument is stronger than a disagreement about clinical criteria. If the reviewer's specialty does not match the question, raise the peer-matching defect explicitly.
Threshold reconciliation matters here. Timeliness standards differ across state law, federal program rules, and accreditation frameworks, and they do not always agree. Where frameworks conflict, the stricter applicable standard generally governs the file. The 5705 signature date should satisfy the strictest clock that applies to that case.
One professional caveat deserves emphasis: accreditation surveys increasingly sample assignment memos directly rather than relying on decision logs. A clean decision record with a messy signature trail still produces findings.
Limitations: what the memo cannot establish
The 5705 memo documents assignment, not quality. A properly signed memo tells you the right authority assigned the right physician at the right time. It says nothing about whether the clinical criteria were applied correctly or whether the reviewer's reasoning was sound.
Documentation practices also vary by organization. Some plans maintain detailed memos with delegation citations; others use abbreviated assignment forms. Absence of a formal memo does not automatically void a review, but it weakens the record considerably.
Regulatory requirements differ by jurisdiction and by payer type, and the specific timelines, delegation rules, and audit expectations attached to peer review assignment change over time. This article describes stable structural principles rather than any single current rule set.
For high-stakes decisions about a specific denial, delegation dispute, or appeal, consult a qualified health care compliance professional or attorney familiar with the governing jurisdiction. This article is general educational information, not a legal opinion or a treatment plan, and it does not promise any outcome in a review or appeal.